Your provider can discuss how your genetic predispositions may inform expected response timelines, potential side effect tolerability, and whether a specific compounded formulation or protocol aligns with your biology
At LIWLI, we choose the medication based on your individual biology, lifestyle, and treatment goals
Medication access concerns drive many transitions, and people report mixed experiences depending on their sources
GLP-1 Market Share, By Indication, 2025 (%) The obesity and weight management segment held a 28% share of the market in 2025 and is expected to grow at the fastest CAGR of 18.6% during the projection period
While there is unquestionable malignant transformation on occasions in these lesions, such events are rare